Logo image of PSTV

PLUS THERAPEUTICS INC (PSTV) Stock Fundamental Analysis

NASDAQ:PSTV - Nasdaq - US72941H5090 - Common Stock - Currency: USD

0.6586  -0.01 (-1.95%)

After market: 0.6301 -0.03 (-4.33%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to PSTV. PSTV was compared to 568 industry peers in the Biotechnology industry. PSTV may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, PSTV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PSTV has reported negative net income.
PSTV had a negative operating cash flow in the past year.
PSTV had negative earnings in each of the past 5 years.
In the past 5 years PSTV always reported negative operating cash flow.
PSTV Yearly Net Income VS EBIT VS OCF VS FCFPSTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of -195.66%, PSTV is doing worse than 89.26% of the companies in the same industry.
Industry RankSector Rank
ROA -195.66%
ROE N/A
ROIC N/A
ROA(3y)-132.52%
ROA(5y)-105.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSTV Yearly ROA, ROE, ROICPSTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PSTV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSTV Yearly Profit, Operating, Gross MarginsPSTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

0

2. Health

2.1 Basic Checks

PSTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
PSTV has more shares outstanding than it did 1 year ago.
PSTV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PSTV is higher compared to a year ago.
PSTV Yearly Shares OutstandingPSTV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
PSTV Yearly Total Debt VS Total AssetsPSTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -112.02, we must say that PSTV is in the distress zone and has some risk of bankruptcy.
PSTV has a Altman-Z score of -112.02. This is amonst the worse of the industry: PSTV underperforms 96.65% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -112.02
ROIC/WACCN/A
WACC9.12%
PSTV Yearly LT Debt VS Equity VS FCFPSTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

PSTV has a Current Ratio of 0.34. This is a bad value and indicates that PSTV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.34, PSTV is not doing good in the industry: 94.54% of the companies in the same industry are doing better.
PSTV has a Quick Ratio of 0.34. This is a bad value and indicates that PSTV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.34, PSTV is not doing good in the industry: 94.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
PSTV Yearly Current Assets VS Current LiabilitesPSTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.10% over the past year.
Looking at the last year, PSTV shows a quite strong growth in Revenue. The Revenue has grown by 18.54% in the last year.
PSTV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.61% yearly.
EPS 1Y (TTM)52.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)18.54%
Revenue growth 3YN/A
Revenue growth 5Y-3.61%
Sales Q2Q%7.54%

3.2 Future

Based on estimates for the next years, PSTV will show a very strong growth in Earnings Per Share. The EPS will grow by 25.24% on average per year.
Based on estimates for the next years, PSTV will show a very strong growth in Revenue. The Revenue will grow by 102.09% on average per year.
EPS Next Y29.96%
EPS Next 2Y13.52%
EPS Next 3Y3.83%
EPS Next 5Y25.24%
Revenue Next Year19.43%
Revenue Next 2Y21.98%
Revenue Next 3Y87.71%
Revenue Next 5Y102.1%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PSTV Yearly Revenue VS EstimatesPSTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
PSTV Yearly EPS VS EstimatesPSTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -500K -1M -1.5M -2M -2.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PSTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PSTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSTV Price Earnings VS Forward Price EarningsPSTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSTV Per share dataPSTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.52%
EPS Next 3Y3.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PSTV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLUS THERAPEUTICS INC

NASDAQ:PSTV (4/17/2025, 8:00:00 PM)

After market: 0.6301 -0.03 (-4.33%)

0.6586

-0.01 (-1.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners8.46%
Inst Owner Change0%
Ins Owners2.55%
Ins Owner Change0%
Market Cap11.20M
Analysts82.22
Price Target10.54 (1500.36%)
Short Float %2.52%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.39%
Min EPS beat(2)3.28%
Max EPS beat(2)35.51%
EPS beat(4)3
Avg EPS beat(4)16.94%
Min EPS beat(4)-3.59%
Max EPS beat(4)35.51%
EPS beat(8)6
Avg EPS beat(8)20.63%
EPS beat(12)7
Avg EPS beat(12)6.77%
EPS beat(16)9
Avg EPS beat(16)4.61%
Revenue beat(2)1
Avg Revenue beat(2)15.8%
Min Revenue beat(2)-5.88%
Max Revenue beat(2)37.49%
Revenue beat(4)1
Avg Revenue beat(4)0.97%
Min Revenue beat(4)-25.16%
Max Revenue beat(4)37.49%
Revenue beat(8)3
Avg Revenue beat(8)14.57%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.81%
PT rev (3m)0.81%
EPS NQ rev (1m)42.16%
EPS NQ rev (3m)37.57%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-14.42%
Revenue NQ rev (3m)-19.82%
Revenue NY rev (1m)34.78%
Revenue NY rev (3m)34.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.92
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.17
EYN/A
EPS(NY)-1.52
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS0.34
BVpS-0.53
TBVpS-0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -195.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-132.52%
ROA(5y)-105.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 95.57%
Cap/Sales 11.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -112.02
F-Score4
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)67.77%
Cap/Depr(5y)74.15%
Cap/Sales(3y)82.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next Y29.96%
EPS Next 2Y13.52%
EPS Next 3Y3.83%
EPS Next 5Y25.24%
Revenue 1Y (TTM)18.54%
Revenue growth 3YN/A
Revenue growth 5Y-3.61%
Sales Q2Q%7.54%
Revenue Next Year19.43%
Revenue Next 2Y21.98%
Revenue Next 3Y87.71%
Revenue Next 5Y102.1%
EBIT growth 1Y-10.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.87%
OCF growth 3YN/A
OCF growth 5YN/A